Medical News

RSS

Proposed Medicare payment changes for hospitals would lower reimbursements slightly

The Wall Street Journal: "Hospital stocks moved higher Tuesday after the agency that runs Medicare proposed new inpatient services rates for the next fiscal year that were somewhat better than many had expected. Monday evening the Centers for Medicare & Medicaid Services said it would like to cut Medicare operating payments to acute care hospitals for inpatient services occurring in the next fiscal year by $142 million, or 0.1%. These figures don't include the impact of the new health-care reform law, which analysts said would cut the rate by another 0.25%".

22 Apr 2010

Study links mutations in RAD51C gene to breast and ovarian cancer

The discovery 15 years ago that the genes BRCA1 and BRCA2 confer high risks for breast and ovarian cancer was a breakthrough for cancer prediction and therapy, especially for familial cases. Now the research group of Prof. Alfons Meindl (Klinikum rechts der Isar of the Technische Universitaet Muenchen), in collaboration with other groups from Germany, the U.K., and the U.S., can identify another gene that increases susceptibility to breast and ovarian cancer.

22 Apr 2010

Aspen Dental donates $2,300 to Oral Cancer Foundation for cancer detection and treatment

Aspen Dental announced today that the company will donate $2,300 to the Oral Cancer Foundation as part of its commitment to oral cancer detection and treatment. The amount represents a $5 donation for every Vizilite Plus screening conducted at Aspen Dental offices during Oral, Head, and Neck Cancer Awareness Week (April 12-18, 2010).

22 Apr 2010

AFP reflects on WHO's response to H1N1

Agence France-Presse examines the WHO's response to H1N1 (swine flu) one year since the virus was first reported in Mexico and the U.S. "A year on, questions linger as to whether a decision by the World Health Organization to declare swine flu a pandemic, thereby unleashing the slew of health measures, was over-dramatic or even tainted by commercial interests," the news service writes.

22 Apr 2010

Nuon Therapeutics advances NU1618 into phase 2b development for chronic hyperuricemia in gout patients

Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that the company is advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. Nuon anticipates releasing topline data from a completed proof-of-principle, phase 2a study of NU1618 in the second quarter of 2010.

22 Apr 2010

Women and men experience different outcomes at U.S. hospitals: HealthGrades

Women and men experience different outcomes at U.S. hospitals for the same procedures and treatments, according to a new study released today by HealthGrades, the leading independent healthcare ratings organization.

22 Apr 2010

NPS Pharmaceuticals closes public offering of common stock shares

NPS Pharmaceuticals, Inc. today announced the closing of a public offering of 10,350,000 shares of its common stock, including 1,350,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. All of the shares were offered by the Company. Net proceeds were approximately $53.3 million after deducting underwriting discounts and commissions, and estimated offering expenses. Canaccord Adams acted as sole book-running manager and Needham & Company, LLC acted as co-manager for the offering.

22 Apr 2010

No more needles for vaccines – a two minute Nanopatch may suffice, say researchers

Vaccines have been associated with painful injections for a very long time. In a new and important discovery researchers have developed special ‘nano patches’ that can deliver vaccines without needles in just two minutes using 100 times less dose than used conventionally.

22 Apr 2010

New Department of Neurosurgery for UNC School of Medicine

The University of North Carolina at Chapel Hill School of Medicine is establishing a new Department of Neurosurgery, effective July 1, 2010.

22 Apr 2010

Infinity Pharmaceuticals initiates Phase 1b/2 trial of IPI-926 Hedgehog pathway inhibitor for pancreatic cancer

Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that it has initiated a randomized Phase 1b/2 clinical trial evaluating IPI-926, its novel, oral Hedgehog pathway inhibitor, in combination with gemcitabine in patients with pancreatic cancer.

22 Apr 2010

Stopping smoking may be harder than quitting heroin

An addiction is an addiction and it may be tougher to quit smoking cigarettes compared to beating a heroin addiction. An Australian study found that many long term smokers have tried to quit 7.4 times but are still unable to do so. Sydney GP Raymond Seidler actually feels that people do not realize that quitting smoking is just as bad as kicking heroin out of your life.

22 Apr 2010

Study: Scientists advance toward development of urine test for detecting colon cancer

Scientists are reporting an advance toward development of a urine test for detecting colon cancer, the third most common cancer in the United States. Such a test could eventually compliment or even reduce the need for colonoscopy, the mainstay screening test used today. The study, which analyzes chemical differences in the urine of humans with and without colon cancer, is in ACS' Journal of Proteome Research, a monthly publication.

22 Apr 2010

Senate Democrats seek legislation to regulate insurer rate hikes

The New York Times: "Fearing that health insurance premiums may shoot up in the next few years, Senate Democrats laid a foundation on Tuesday for federal regulation of rates, four weeks after President Obama signed a law intended to rein in soaring health costs." Sen. Dianne Feinstein, D-Calif., introduced legislation that would allow the federal health secretary to block "any rate increase found to be unreasonable," an authority that would be shared with some state insurance officials.

22 Apr 2010

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

Salix Pharmaceuticals, Ltd. today announced that the Company will host a DDW2010 Investor Event on Monday, May 3 2010 from 9:00 p.m. to 10:00 p.m. Central Time (10:00 p.m. to 11:00 p.m. ET).

22 Apr 2010

Young Innovations' first-quarter sales increases 4.3% to $24.8M

Young Innovations, Inc. today announced record sales and earnings per share for the quarter ended March 31, 2010.

22 Apr 2010

Clinical Xpert suite of mobile clinical workflow solutions available to clinicians

Thomson Reuters announced today that it will support the iPhone platform for its Clinical Xpert suite of mobile clinical workflow solutions.

22 Apr 2010

Delcath Systems' trial meets primary endpoint of extended hPFS in patients with melanoma metastases

Delcath Systems, Inc., a development stage, oncology-focused, specialty pharmaceutical and medical device company, announced that its Phase III National Cancer Institute (NCI)-led multi-center clinical trial has successfully met the study's primary endpoint of extended hepatic progression-free survival (hPFS) in patients with melanoma metastases to the liver based on an independently corroborated intent-to-treat analysis.

22 Apr 2010

2008 Physical Activity Guidelines for Americans interpreted for practical use by health care professionals

The first formal U.S. government recommendations on physical activity, the Physical Activity Guidelines for Americans, were published in 2008. Now, those guidelines have been interpreted for practical use by health care professionals in the American Journal of Lifestyle Medicine, published by SAGE.

22 Apr 2010

Obama puts health care on 'back burner'

The Washington Post: President Barack Obama seems to have put health care on the back burner as he focuses on financial reform and nuclear proliferation.

22 Apr 2010

Affymetrix reports first-quarter total revenue of $80.2M

Affymetrix, Inc., today reported its operating results for the first quarter of 2010. Total revenue for the quarter was $80.2 million, as compared to total revenue of $78.6 million in the first quarter of 2009.

22 Apr 2010

Medical News

Proposed Medicare payment changes for hospitals would lower reimbursements slightly

Study links mutations in RAD51C gene to breast and ovarian cancer

Aspen Dental donates $2,300 to Oral Cancer Foundation for cancer detection and treatment

AFP reflects on WHO's response to H1N1

Nuon Therapeutics advances NU1618 into phase 2b development for chronic hyperuricemia in gout patients

Women and men experience different outcomes at U.S. hospitals: HealthGrades

NPS Pharmaceuticals closes public offering of common stock shares

No more needles for vaccines – a two minute Nanopatch may suffice, say researchers

New Department of Neurosurgery for UNC School of Medicine

Infinity Pharmaceuticals initiates Phase 1b/2 trial of IPI-926 Hedgehog pathway inhibitor for pancreatic cancer

Stopping smoking may be harder than quitting heroin

Study: Scientists advance toward development of urine test for detecting colon cancer

Senate Democrats seek legislation to regulate insurer rate hikes

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

Young Innovations' first-quarter sales increases 4.3% to $24.8M

Clinical Xpert suite of mobile clinical workflow solutions available to clinicians

Delcath Systems' trial meets primary endpoint of extended hPFS in patients with melanoma metastases

2008 Physical Activity Guidelines for Americans interpreted for practical use by health care professionals

Obama puts health care on 'back burner'

Affymetrix reports first-quarter total revenue of $80.2M

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News